PELUSO STEPHANE (Chief Scientific Officer) purchased 68.0% of their position (14.99K shares) of INFINITY PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $9.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/4/2022ACC: 0001140361-22-028234
Officer· Chief Scientific Officer
Since Aug 2021
+14.99K
Net shares
Net buyer
$9.9K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
64.99K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
2443.8%
8/2/2022
2.05K→52.05K
Common Stock
Direct
Shares
+14.99K
Price / share
$0.66
Trade value
$9.93K
% of position
68.0%
8/2/2022
22.06K→37.05K
Total
Net shares
+64.99K
Net value
$9.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/2/2022 | M · Option Exercise | +50K | — | — | 2443.8% | 2.05K | 52.05K |
| Common Stock Direct | 8/2/2022 | S · Sale | +14.99K | $0.66 | $9.93K | 68.0% | 22.06K | 37.05K |
| Total | +64.99K | $9.93K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
Held after
0.00
Exercisable
—
8/2/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock50K shares | 8/2/2022 | M · Option Exercise | −50K | — | 0.00 |